search
Back to results

ISB, SSNB, and PENG Block for Arthroscopic Shoulder Surgery

Primary Purpose

Interscalene Nerve Block, Anterior Suprascapular Nerve Block, Arthroscopic Shoulder Surgery

Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
interscalene nerve block
anterior suprascapular nerve block
Peri-capsular nerve group block
Sponsored by
Tanta University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Interscalene Nerve Block

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Adult patients. ASA class I and II and scheduled for elective shoulder arthroscopy. Exclusion Criteria: Patient who refuses the regional anesthesia technique. History of allergy to local anesthetics. Local infection at the site of the block. History of Pre-existing major organ dysfunction such as hepatic and renal failure. History of pre-existing lung disease (COPD, uncontrolled asthma). Preexisting upper extremity neurological abnormality or neuropathy. Difficulties in comprehending (NRS). Chronic opioid users (opioid intake more than 3 months).

Sites / Locations

  • Shrouk Mohamed ElsawafRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Group (I)

Group (II)

Group (III)

Arm Description

30 patients will receive interscalene nerve block.

30 Patients will receive anterior suprascapular nerve block.

30 atients will receive pericapsular nerve group block around shoulder surgery

Outcomes

Primary Outcome Measures

the total opioid consumption.
Postoperative analgesia will be assessed by total opioid consumption and time till administration of first rescue analgesia will be recorded.

Secondary Outcome Measures

Full Information

First Posted
February 13, 2023
Last Updated
September 2, 2023
Sponsor
Tanta University
search

1. Study Identification

Unique Protocol Identification Number
NCT05739201
Brief Title
ISB, SSNB, and PENG Block for Arthroscopic Shoulder Surgery
Official Title
Comparative Study Between Interscalene Nerve Block, Anterior Suprascapular Nerve Block, and Pericapsular Nerve Group Block for Arthroscopic Shoulder Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 20, 2023 (Actual)
Primary Completion Date
December 20, 2023 (Anticipated)
Study Completion Date
December 20, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tanta University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is designed to investigate the post-operative analgesic effect of interscalene nerve block or anterior suprascapular nerve block compared to pericapsular nerve group block in patient undergoing elective arthroscopic shoulder surgery.
Detailed Description
Shoulder arthroscopy is a common outpatient operation with an increasing number of indications and complexity. Early postoperative pain immediately following shoulder surgery is a major concern and cause of distress for patients and orthopedic surgeons. Adequate pain control is vital for all aspects of the patient's recovery. Nowadays, several ultrasound -guided regional anesthesia methods are used for postoperative analgesia. Regional techniques such as interscalene and supraclavicular blocks are usually preferred for shoulder analgesia. Interscalene brachial plexus block (ISB) is the gold standard technique in this area. Suprascapular nerve block (SSB) has been proposed as an alternative to the ISB in providing analgesia for shoulder surgeries as it has a lower likelihood of causing phrenic nerve blockade. The pericapsular nerve group (PENG) block has been suggested to be safely applied for analgesia and can be part of surgical anesthesia, but alone is not sufficient for anesthesia in shoulder surgery. The block of this area did not cause motor block or pulmonary complications, nor result in muscle laxity, blocking only the shoulder and the upper third of the humerus.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Interscalene Nerve Block, Anterior Suprascapular Nerve Block, Arthroscopic Shoulder Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group (I)
Arm Type
Active Comparator
Arm Description
30 patients will receive interscalene nerve block.
Arm Title
Group (II)
Arm Type
Active Comparator
Arm Description
30 Patients will receive anterior suprascapular nerve block.
Arm Title
Group (III)
Arm Type
Active Comparator
Arm Description
30 atients will receive pericapsular nerve group block around shoulder surgery
Intervention Type
Procedure
Intervention Name(s)
interscalene nerve block
Intervention Description
Patients will receive interscalene nerve block, in which the patient will be in supine position with the head turned to the contralateral side using an ultrasound scan to identify the C5 and C6 nerve roots between the scalene muscles.15 ml of 0.25% Bupivacaine will be deposited between the C5 and C6 nerve roots, within the interscalene groove using a 22 gauge-regional block needle.
Intervention Type
Procedure
Intervention Name(s)
anterior suprascapular nerve block
Intervention Description
Patients will receive anterior suprascapular nerve block, in which the patient will be in supine position with the head turned to the contralateral side, using an ultrasound the nerve will be traced as it diverges from the brachial plexus to lie under the omohyoid muscle in the supraclavicular fossa. 15 ml of 0.25% Bupivacaine will be deposited lateral to the suprascapular nerve, underneath the omohyoid muscle using a 22 gauge-regional block needle.
Intervention Type
Procedure
Intervention Name(s)
Peri-capsular nerve group block
Intervention Description
Patients will receive PENG block, in which the patient will be in supine position and the patient's arm will be placed in external rotation and abducted at 45 degrees, using an ultrasound the humeral head, the tendon of the subscapularis muscle and the deltoid muscle over it will be defined, 15 ml of 0.25% Bupivacaine will be placed between the deltoid muscle and subscapularis tendon using a 22 gauge-regional block needle.
Primary Outcome Measure Information:
Title
the total opioid consumption.
Description
Postoperative analgesia will be assessed by total opioid consumption and time till administration of first rescue analgesia will be recorded.
Time Frame
24-hour postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients. ASA class I and II and scheduled for elective shoulder arthroscopy. Exclusion Criteria: Patient who refuses the regional anesthesia technique. History of allergy to local anesthetics. Local infection at the site of the block. History of Pre-existing major organ dysfunction such as hepatic and renal failure. History of pre-existing lung disease (COPD, uncontrolled asthma). Preexisting upper extremity neurological abnormality or neuropathy. Difficulties in comprehending (NRS). Chronic opioid users (opioid intake more than 3 months).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Shrouk M Elsawaf, Master
Phone
+201091533902
Ext
+20
Email
Shroukms95@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ayman A Youssef, MD
Organizational Affiliation
Professor of Anaesthesiology, Surgical Intensive Care and Pain Therapy, Faculty of Medicine, Tanta University, Egypt
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shrouk Mohamed Elsawaf
City
Tanta
State/Province
EL-Gharbia
ZIP/Postal Code
31527
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shrouk M Elsawaf, Master
Phone
01091533902
Ext
+20
Email
Shroukms95@gmail.com

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
The data will be available upon reasonable request from the principal investigator
IPD Sharing Time Frame
one year

Learn more about this trial

ISB, SSNB, and PENG Block for Arthroscopic Shoulder Surgery

We'll reach out to this number within 24 hrs